Medical technology company Monivent has reached an agreement with its lenders to extend the maturity date of the SEK 8 million bridge loan originally secured in September 2024. The maturity date has been pushed back from March 31 to May 31 of this year, while all other loan terms remain unchanged.

The bridge loan was provided by a consortium of five lenders who are also existing shareholders, including the company's largest shareholder, the Chairman of the Board, and an additional board member.

Monivent continues to work toward securing long-term financing.